AN2 Therapeutics
ANTX
#8920
Rank
A$0.29 B
Marketcap
A$7.67
Share price
-2.68%
Change (1 day)
354.74%
Change (1 year)

EPS for AN2 Therapeutics (ANTX)

EPS in 2026 (TTM): A-$1.58

According to AN2 Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.62. In 2025 the company made an earnings per share (EPS) of A-$1.75 an increase over its 2024 EPS that were of A-$2.60.

EPS history for AN2 Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.58-9.77%
2025A-$1.75-32.56%
2024A-$2.60-39.01%
2023A-$4.26-40.02%
2022A-$7.10